Founded in 1974, Pro-Lab Diagnostics is a privately held corporation based in Ontario, Canada, with subsidiaries in the UK and the US. The company is registered under ISO 13585:2003 (CMDCAS) and is approved by Health Canada and the FDA. Pro-Lab Diagnostics conducts extensive research and development to produce high-quality and cost-effective immunodiagnostic reagents. They also distribute innovative products from leading companies worldwide, covering various disciplines such as Clinical Microbiology, Molecular Biology, and Transfusion Medicine. Additionally, Pro-Lab specializes in private label packaging and welcomes new business opportunities. Their product range includes ELISA kits, bacterial preservation, and pH tests. Notable products include AmnioTest™, a POC screen test for detecting fetal membrane rupture, and Prolisa™ Enzyme Immunoassay System, which detects Clostridium difficile glutamate dehydrogenase and Shiga Toxins I and II. Pro-Lab Diagnostics serves hospitals, medical laboratories, and other biological investigative laboratories, ensuring high-quality products that meet governmental standards.